175 related articles for article (PubMed ID: 35115664)
1. Distinct molecular phenotypes involving several human diseases are induced by IFN-λ3 and IFN-λ4 in monocyte-derived macrophages.
De M; Bhushan A; Grubbe WS; Roy S; Mendoza JL; Chinnaswamy S
Genes Immun; 2022 Apr; 23(2):73-84. PubMed ID: 35115664
[TBL] [Abstract][Full Text] [Related]
2. Monocytes differentiated into macrophages and dendritic cells in the presence of human IFN-λ3 or IFN-λ4 show distinct phenotypes.
De M; Bhushan A; Chinnaswamy S
J Leukoc Biol; 2021 Aug; 110(2):357-374. PubMed ID: 33205487
[TBL] [Abstract][Full Text] [Related]
3. Identifying causal variants at the interferon lambda locus in case-control studies: Utilizing non-synonymous variant rs117648444 to probe the role of IFN-λ4.
Bhushan A; Chinnaswamy S
Gene; 2018 Jul; 664():168-180. PubMed ID: 29705128
[TBL] [Abstract][Full Text] [Related]
4. Gender-dependent multiple cross-phenotype association of interferon lambda genetic variants with peripheral blood profiles in healthy individuals.
Roy DG; Singh L; Chaturvedi HK; Chinnaswamy S
Mol Genet Genomic Med; 2024 Jan; 12(1):e2292. PubMed ID: 37795763
[TBL] [Abstract][Full Text] [Related]
5. IFN-λ3, not IFN-λ4, likely mediates IFNL3-IFNL4 haplotype-dependent hepatic inflammation and fibrosis.
Eslam M; McLeod D; Kelaeng KS; Mangia A; Berg T; Thabet K; Irving WL; Dore GJ; Sheridan D; Grønbæk H; Abate ML; Hartmann R; Bugianesi E; Spengler U; Rojas A; Booth DR; Weltman M; Mollison L; Cheng W; Riordan S; Mahajan H; Fischer J; Nattermann J; Douglas MW; Liddle C; Powell E; Romero-Gomez M; George J;
Nat Genet; 2017 May; 49(5):795-800. PubMed ID: 28394349
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus and interferon type III (interferon-λ3/interleukin-28B and interferon-λ4): genetic basis of susceptibility to infection and response to antiviral treatment.
Riva E; Scagnolari C; Turriziani O; Antonelli G
Clin Microbiol Infect; 2014 Dec; 20(12):1237-45. PubMed ID: 25273834
[TBL] [Abstract][Full Text] [Related]
7. Genetics of the Human Interferon Lambda Region.
Prokunina-Olsson L
J Interferon Cytokine Res; 2019 Oct; 39(10):599-608. PubMed ID: 31070498
[TBL] [Abstract][Full Text] [Related]
8. Characterization and expression profiling of buffalo IFN-lambda family.
Gautam D; Sindhu A; Vats A; Rajput S; Roshan M; Pal H; De S
Vet Immunol Immunopathol; 2024 Jun; 272():110770. PubMed ID: 38735115
[TBL] [Abstract][Full Text] [Related]
9. The Genetic Association of IFN-λs with Human Inflammatory Disorders Remains a Conundrum.
Chinnaswamy S; Kowalski ML
J Interferon Cytokine Res; 2019 Oct; 39(10):594-598. PubMed ID: 31161954
[TBL] [Abstract][Full Text] [Related]
10. Design and evaluation of novel interferon lambda analogs with enhanced antiviral activity and improved drug attributes.
Yu D; Zhao M; Dong L; Zhao L; Zou M; Sun H; Zhang M; Liu H; Zou Z
Drug Des Devel Ther; 2016; 10():163-82. PubMed ID: 26792983
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of interferon-lambda receptor 1 splice variants determines the magnitude of the antiviral response induced by interferon-lambda 3 in human immune cells.
Santer DM; Minty GES; Golec DP; Lu J; May J; Namdar A; Shah J; Elahi S; Proud D; Joyce M; Tyrrell DL; Houghton M
PLoS Pathog; 2020 Apr; 16(4):e1008515. PubMed ID: 32353085
[TBL] [Abstract][Full Text] [Related]
12. IFN-λ4 Attenuates Antiviral Responses by Enhancing Negative Regulation of IFN Signaling.
Obajemu AA; Rao N; Dilley KA; Vargas JM; Sheikh F; Donnelly RP; Shabman RS; Meissner EG; Prokunina-Olsson L; Onabajo OO
J Immunol; 2017 Dec; 199(11):3808-3820. PubMed ID: 29070670
[TBL] [Abstract][Full Text] [Related]
13. Type III Interferons in Hepatitis C Virus Infection.
Boisvert M; Shoukry NH
Front Immunol; 2016; 7():628. PubMed ID: 28066437
[TBL] [Abstract][Full Text] [Related]
14. IFN-λ4: the paradoxical new member of the interferon lambda family.
O'Brien TR; Prokunina-Olsson L; Donnelly RP
J Interferon Cytokine Res; 2014 Nov; 34(11):829-38. PubMed ID: 24786669
[TBL] [Abstract][Full Text] [Related]
15. Porcine interferon lambda 3 (IFN-λ3) shows potent anti-PRRSV activity in primary porcine alveolar macrophages (PAMs).
Zhao J; Zhu L; Xu L; Huang J; Sun X; Xu Z
BMC Vet Res; 2020 Oct; 16(1):408. PubMed ID: 33115475
[TBL] [Abstract][Full Text] [Related]
16. Functional genetic variants of the IFN-λ3 (IL28B) gene and transcription factor interactions on its promoter.
Roy S; Guha Roy D; Bhushan A; Bharatiya S; Chinnaswamy S
Cytokine; 2021 Jun; 142():155491. PubMed ID: 33725487
[TBL] [Abstract][Full Text] [Related]
17. Different Mechanisms Are Utilized by Coronavirus Transmissible Gastroenteritis Virus To Regulate Interferon Lambda 1 and Interferon Lambda 3 Production.
Xue M; Wang W; He H; Li L; Zhang X; Shi H; Liu P; Feng L
J Virol; 2022 Dec; 96(24):e0138822. PubMed ID: 36448799
[TBL] [Abstract][Full Text] [Related]
18. IFN-λ4 inhibits HIV infection of macrophages through signalling of IFN-λR1/IL-10R2 receptor complex.
Su QJ; Wang X; Zhou RH; Guo L; Liu H; Li JL; Ho WZ
Scand J Immunol; 2018 Nov; 88(5):e12717. PubMed ID: 30247785
[TBL] [Abstract][Full Text] [Related]
19. Genetic Polymorphisms within Interferon-λ Region and Interferon-λ3 in the Human Pathophysiology: Their Contribution to Outcome, Treatment, and Prevention of Infections with Hepatotropic Viruses.
Grzegorzewska AE
Curr Med Chem; 2019; 26(25):4832-4851. PubMed ID: 30027841
[TBL] [Abstract][Full Text] [Related]
20. Species Specificity of Type III Interferon Activity and Development of a Sensitive Luciferase-Based Bioassay for Quantitation of Mouse Interferon-λ.
Jacobs S; Wavreil F; Schepens B; Gad HH; Hartmann R; Rocha-Pereira J; Neyts J; Saelens X; Michiels T
J Interferon Cytokine Res; 2018 Nov; 38(11):469-479. PubMed ID: 30335553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
